Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial
Crossref DOI link: https://doi.org/10.1245/s10434-023-14766-9
Published Online: 2023-12-21
Published Print: 2024-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khattak, Monica N.
Chichura, Anna M.
Lang, Julie E. http://orcid.org/0000-0002-7534-6124
Text and Data Mining valid from 2023-12-21
Version of Record valid from 2023-12-21
Article History
Received: 27 October 2023
Accepted: 27 November 2023
First Online: 21 December 2023
Free to read: This content has been made available to all.